Health / Health tech / Investing / Startups

Clear Guide Medical closes $1.5 million Series A

And another $1.5 million could be on the way. The startup's biopsy imaging tools also have FDA approval.

Clear Guide Medical's SCENERGY and SuperPROBE in action. (Image via YouTube)

A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.
The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals.  The startup is looking to expand sales in the U.S. and Europe.

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


He started at Neya as an intern. 10 years later, he’s director of robotics — and loving life

Entrepreneurs need housing more than tax policy

Maryland Tech Council honors global companies, startups and youth as ICONs

What technology puts on display and why

Technically Media